Our results showed that DCQD could improve the intestinal barrier function by reducing inflammatory factors such as HMGB1 in the intestine, reduce their translocation through the intestinal lymphatic pathway and reduce the inflammatory response induced by HMGB1, which plays an important role in the treatment of SAP-ALI. The gene discussed is HMGB1; the disease is acute respiratory distress syndrome.